- Home
- TRIP vs ARWR Comparison
TRIP vs ARWR Comparison
Compare TRIP & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRIP
- ARWR
- Stock Information
- Founded
- TRIP 2000
- ARWR 2003
- Country
- TRIP United States
- ARWR United States
- Employees
- TRIP N/A
- ARWR N/A
- Industry
- TRIP Computer Software: Programming Data Processing
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- TRIP Technology
- ARWR Health Care
- Exchange
- TRIP Nasdaq
- ARWR Nasdaq
- Market Cap
- TRIP 1.6B
- ARWR 1.7B
- IPO Year
- TRIP 2011
- ARWR 1993
- Fundamental
- Price
- TRIP $11.72
- ARWR $11.24
- Analyst Decision
- TRIP Hold
- ARWR Buy
- Analyst Count
- TRIP 14
- ARWR 11
- Target Price
- TRIP $17.57
- ARWR $41.44
- AVG Volume (30 Days)
- TRIP 2.8M
- ARWR 2.3M
- Earning Date
- TRIP 05-07-2025
- ARWR 05-08-2025
- Dividend Yield
- TRIP N/A
- ARWR N/A
- EPS Growth
- TRIP N/A
- ARWR N/A
- EPS
- TRIP 0.04
- ARWR N/A
- Revenue
- TRIP $1,835,000,000.00
- ARWR $2,500,000.00
- Revenue This Year
- TRIP $6.87
- ARWR $4,380.43
- Revenue Next Year
- TRIP $7.19
- ARWR $64.24
- P/E Ratio
- TRIP $329.05
- ARWR N/A
- Revenue Growth
- TRIP 2.63
- ARWR N/A
- 52 Week Low
- TRIP $10.43
- ARWR $9.57
- 52 Week High
- TRIP $27.63
- ARWR $30.41
- Technical
- Relative Strength Index (RSI)
- TRIP 38.37
- ARWR 38.40
- Support Level
- TRIP $10.43
- ARWR $9.64
- Resistance Level
- TRIP $11.95
- ARWR $12.93
- Average True Range (ATR)
- TRIP 0.85
- ARWR 1.18
- MACD
- TRIP -0.05
- ARWR 0.18
- Stochastic Oscillator
- TRIP 32.01
- ARWR 43.21
About TRIP TripAdvisor Inc.
Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on several million accommodations, restaurants, experiences, airlines, and cruises. In 2024, 52% of revenue came from the company's core Brand Tripadvisor segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 46% of sales in 2024, and TheFork, its dining brand, represented 10% of revenue (about 8% of sales were intersegment, which are eliminated from consolidated revenue).
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.